HomeACUR • OTCMKTS
add
Acura Pharmaceuticals Inc
Nakaraang pagsara
$0.00020
Sakop ng taon
$0.00020 - $0.75
Market cap
13.27K USD
Average na Volume
3.67K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga balita tungkol sa merkado
Investing.com
35 minuto ang nakalipas
Capital Economics says rebound in Nasdaq, growth stocks is close
0.26%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | 2021info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.56M | -56.22% |
Gastos sa pagpapatakbo | 1.25M | -33.32% |
Net na kita | -879.00K | 27.24% |
Net profit margin | -56.24 | -66.19% |
Kita sa bawat share | — | — |
EBITDA | -1.14M | -3,360.00% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | 2021info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 65.00K | -84.26% |
Kabuuang asset | 860.00K | -50.46% |
Kabuuang sagutin | 682.00K | -91.06% |
Kabuuang equity | 178.00K | — |
Natitirang share | 66.00M | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -58.46% | — |
Return on capital | -200.73% | — |
Cash Flow
Net change in cash
| (USD) | 2021info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -879.00K | 27.24% |
Cash mula sa mga operasyon | -742.00K | -3.20% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 394.00K | 45.93% |
Net change in cash | -348.00K | 22.49% |
Malayang cash flow | -1.10M | -238.17% |
Tungkol
Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR". Wikipedia
Itinatag
1935
Headquarters
Website
Mga Empleyado
9
